WST West Pharmaceutical Services, Inc. Common Stock

NYSE · US · Healthcare · Medical Instruments & Supplies · westpharma.com

364.98USD-0.01%Mkt Cap: 25.69B $P/E: 46.793d ago

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

BLCO

Bausch + Lomb Corporation Common Shares

$6.11BUSD

Key Statistics

Company

Market Cap25.69B USD

Enterprise Value25.57B USD

Revenue (TTM)3.33B USD

Gross Profit1.10B USD

Net Income (TTM)493.70M USD

Revenue/Share46.30 USD

Last Price364.98 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees10.8K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)46.79

P/E (Forward)36.56

PEG2.89

EV/EBITDA28.03

EV/Revenue7.69

P/S7.72

P/B8.59

EPS (TTM)7.80

EPS (Forward)9.98

52W Range

223.8387% of range386.00

52W High386.00 USD

52W Low223.83 USD

Profitability

Gross Margin35.91%

Oper. Margin22.47%

EBITDA Margin27.42%

Profit Margin16.06%

ROE15.54%

ROA11.56%

Growth

Revenue Growth13.80%

Earnings Growth18.10%

Cash Flow & Leverage

Operating CF754.80M USD

CapEx (TTM)285.90M USD

FCF Margin8.35%

FCF Yield1.08%

Net Debt-119.30M USD

Net Debt/EBITDA-0.13

Balance Sheet

Debt/Equity0.10

Current Ratio2.82

Quick Ratio1.82

Book Value/Sh42.47 USD

Cash/Share6.19 USD

Dividends

Fwd Div Rate0.88 USD

Trail. Div Rate0.87 USD

Div. Yield0.24%

5Y Avg Yield0.25%

Payout Ratio11.14%

Ex-Div DateJul 29, 2026

Pay DateAug 5, 2026

Splits

Last Split2:1

Split DateSep 27, 2013

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)407.56 USD

Upside (mean)+11.7%

Target Range340.00 USD – 459.00 USD

340.00+11.7% to mean459.00

# Analysts16

Ownership

Shares Out.70.38M

Float69.85M

Insiders0.66%

Institutions101.93%

Short Interest

Short Ratio4.9d

Short % Float3.95%

Short % Out.3.38%

Shares Short2.38M

Short (prev mo.)2.12M

Technical

SMA 50351.51 (+3.8%)

SMA 200301.37 (+21.1%)

Beta1.14

S&P 52W Chg13.94%

Avg Vol (30d)552.28K

Avg Vol (10d)679.29K

Technical Indicators

RSI (14)54.2

MACD5.8989

MACD Signal6.0132

MACD Hist.-0.1143

BB Upper387.47 USD

BB Middle361.10 USD

BB Lower334.74 USD

BB Width14.60%

ATR (14)8.065 USD

Vol Ratio (20d)0.77x